Answer
Kisunla (donanemab) is not recommended during pregnancy because human pregnancy data are absent or limited and animal studies are insufficient regarding reproductive toxicity.
Sources for this answer
- Kisunla 350 mg concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked